Dr Katherine M Berg, MD | |
330 Brookline Ave, Kirstein Basement, Boston, MA 02215-5400 | |
(617) 667-5864 | |
(617) 667-4849 |
Full Name | Dr Katherine M Berg |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 18 Years |
Location | 330 Brookline Ave, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982814869 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 237578 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
Many of the statements made in health care TV ads are "misleading - if not flat-out wrong," The San Francisco Chronicle reports. Those statements include claims that reform would "'ration' care to the nation's oldest citizens and hike premiums '95 percent.'" Already, more that $67 million has been spent on TV advertising, according to Campaign Media Analysis Group, "and more misinformation and nastiness is expected when Congress returns next week."
British Heart Foundation (BHF) researchers Dr Elinor Griffiths and Dr Andy James and the rest of the team at the Bristol Heart Institute joined up with BHF fundraisers Paul Bancroft and Lucy Culverhouse to launch the BHF Help a Heart Campaign in Bristol this week (Monday 9 June) at Bristol University.
Increasing levels of a protein that helps the brain use cholesterol may slow the development of Alzheimer's disease changes in the brain, according to researchers studying a mouse model of the disease at Washington University School of Medicine in St. Louis.
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
› Verified 1 days ago
Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918 |
News Archive
Many of the statements made in health care TV ads are "misleading - if not flat-out wrong," The San Francisco Chronicle reports. Those statements include claims that reform would "'ration' care to the nation's oldest citizens and hike premiums '95 percent.'" Already, more that $67 million has been spent on TV advertising, according to Campaign Media Analysis Group, "and more misinformation and nastiness is expected when Congress returns next week."
British Heart Foundation (BHF) researchers Dr Elinor Griffiths and Dr Andy James and the rest of the team at the Bristol Heart Institute joined up with BHF fundraisers Paul Bancroft and Lucy Culverhouse to launch the BHF Help a Heart Campaign in Bristol this week (Monday 9 June) at Bristol University.
Increasing levels of a protein that helps the brain use cholesterol may slow the development of Alzheimer's disease changes in the brain, according to researchers studying a mouse model of the disease at Washington University School of Medicine in St. Louis.
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
› Verified 1 days ago
Entity Name | Beth Israel Deaconess Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548202641 PECOS PAC ID: 8123936119 Enrollment ID: O20041001000827 |
News Archive
Many of the statements made in health care TV ads are "misleading - if not flat-out wrong," The San Francisco Chronicle reports. Those statements include claims that reform would "'ration' care to the nation's oldest citizens and hike premiums '95 percent.'" Already, more that $67 million has been spent on TV advertising, according to Campaign Media Analysis Group, "and more misinformation and nastiness is expected when Congress returns next week."
British Heart Foundation (BHF) researchers Dr Elinor Griffiths and Dr Andy James and the rest of the team at the Bristol Heart Institute joined up with BHF fundraisers Paul Bancroft and Lucy Culverhouse to launch the BHF Help a Heart Campaign in Bristol this week (Monday 9 June) at Bristol University.
Increasing levels of a protein that helps the brain use cholesterol may slow the development of Alzheimer's disease changes in the brain, according to researchers studying a mouse model of the disease at Washington University School of Medicine in St. Louis.
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
› Verified 1 days ago
Entity Name | Cambridge Public Health Commission |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932313228 PECOS PAC ID: 8921910894 Enrollment ID: O20050808000725 |
News Archive
Many of the statements made in health care TV ads are "misleading - if not flat-out wrong," The San Francisco Chronicle reports. Those statements include claims that reform would "'ration' care to the nation's oldest citizens and hike premiums '95 percent.'" Already, more that $67 million has been spent on TV advertising, according to Campaign Media Analysis Group, "and more misinformation and nastiness is expected when Congress returns next week."
British Heart Foundation (BHF) researchers Dr Elinor Griffiths and Dr Andy James and the rest of the team at the Bristol Heart Institute joined up with BHF fundraisers Paul Bancroft and Lucy Culverhouse to launch the BHF Help a Heart Campaign in Bristol this week (Monday 9 June) at Bristol University.
Increasing levels of a protein that helps the brain use cholesterol may slow the development of Alzheimer's disease changes in the brain, according to researchers studying a mouse model of the disease at Washington University School of Medicine in St. Louis.
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Katherine M Berg, MD 330 Brookline Ave, Kirstein Basement, Boston, MA 02215-5400 Ph: (617) 667-5864 | Dr Katherine M Berg, MD 330 Brookline Ave, Kirstein Basement, Boston, MA 02215-5400 Ph: (617) 667-5864 |
News Archive
Many of the statements made in health care TV ads are "misleading - if not flat-out wrong," The San Francisco Chronicle reports. Those statements include claims that reform would "'ration' care to the nation's oldest citizens and hike premiums '95 percent.'" Already, more that $67 million has been spent on TV advertising, according to Campaign Media Analysis Group, "and more misinformation and nastiness is expected when Congress returns next week."
British Heart Foundation (BHF) researchers Dr Elinor Griffiths and Dr Andy James and the rest of the team at the Bristol Heart Institute joined up with BHF fundraisers Paul Bancroft and Lucy Culverhouse to launch the BHF Help a Heart Campaign in Bristol this week (Monday 9 June) at Bristol University.
Increasing levels of a protein that helps the brain use cholesterol may slow the development of Alzheimer's disease changes in the brain, according to researchers studying a mouse model of the disease at Washington University School of Medicine in St. Louis.
A novel imaging test shows promise for identifying kidney cancer patients most likely to benefit from immunotherapy.
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a $244,479 grant under The Patient Protection and Affordable Care Act of 2010 (PPACA). The grant was related to the development of ImmunGene's technology which is based on antibody-cytokine fusions that have demonstrated targeted toxicity and added tumor benefits.
› Verified 1 days ago
Kaitlyn My-tu Lam, MBBS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |